Practices
Industries

Sanctions Watch in Russia: Advising Business

02 May 2023
A combination of extensive and complex trade sanctions and export controls against Russia imposed by EU, US and UK starting February 24th 2022 inevitably affected local and multinational companies in Russia. In response the Russian government imposed its own retaliatory measures affecting the business in the country.

Lidings closely monitors the developments of the current situation and offers complex assistance on various issues related to sanctions, helping our clients to maintain operations under the conditions of turbulence and elevated risks.

Experiment on Remote Sale of Prescription Medicines

26 April 2023

On 22 February 2023 the Government has approved the rules for conducting an experiment on the remote sale of prescription medicines. The experiment is carried out in the territory of Moscow, Moscow and Belgorod regions from 1 March 2023 to 1 March 2026.

Lidings – Strategic Partner of the Conference on Legal Issues in Pharmaceutical Industry

26 April 2023

April 26th,2023 annual conference Pharmaceuticals – 2023: Legal Issues will take place in Moscow organized by Pravo.ru. Lidings lawyers take an active part in the event’s program.

As a strategic partner of the conference, we aimed to make the program rich and actual. Together with pharmaceutical industry experts and lawyers, we will discuss topical issues of industry regulation, changes in the pharmaceutical market in the ongoing era of sanctions and talk about how to protect intellectual property.

Restrictions on Import of Unregistered Medicinal Drugs and Medical Devices Can be Amended

24 April 2023

The State Duma has adopted in the first reading amendments to article 238.1 of Criminal Code, establishing liability for circulation of unregistered medicinal drugs and devices in Russia.

The bill proposes to exclude from note 3 to the article 238.1 a case of non–criminalization – the existence of a recommendation by the World Health Organization for the use of appropriate unregistered medicinal drugs and devices.